Clinical Trials Browser

OTHER × Lung Neoplasms × capmatinib × Clear all

NCT03192501 2024-06-25

iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray

Lung Neoplasms, Neoplasms

NCT05435846 2024-06-11

Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms